Clinical Trial of Aripiprazol in Fragile X Syndrome

Clinical Trial of Aripiprazol in Fragile X Syndrome

With a FRAXA Research Foundation grant of $30,000 in 2006, Dr. Erickson conducted a pilot clinical trial of an available medicine, aripiprazole (brand-name Abilify). This was an open-label 12-week trial in 12 people aged 6–25 years with fragile X. Results were promising, and published: 10 of the 12 participants showed behavioral improvements.

Read more